Find the right Irish startup investor by matching stage, sector, operating geography and the milestone the next round must finance. A software company preparing for US expansion needs a different conversation from a medical-device team, a western-region manufacturer or a mature impact business.
This guide compares 18 selected venture managers, specialist investors and clearly labeled public or angel routes. It adds national and cross-border context to the established Dublin guide, including western-region finance, Cork's blue-economy expertise and the distinction between company funding and investment products.
Start with the financing decision, not a list of logos
- Define the company's next proof point. State the customer, technical or commercial result that the next financing must achieve.
- Choose the capital type. A venture fund, angel network, public co-investor, lender and company builder serve different jobs. Keep instruments and counterparties separate.
- Map the operating facts. Republic of Ireland, Northern Ireland, European expansion and US program participation are not the same geographic condition.
- Identify the current team and route. A fund manager's website can contain LP subscriptions, portfolio support and founder applications. Use the founder-facing process.
Compare 18 Irish investor routes
Use provider type, stage and geographic connection together. An office address is not a promise of eligibility. Where the current source does not establish a precise entry stage, the table leaves that question open.
Selected capital providers relevant to Irish startups, researched October 29, 2026. Local, regional and international program routes are labeled separately. On small screens, scroll the table sideways to see every column.
| Investor or network | Provider type | Stage | Sector focus | Geographic connection |
|---|---|---|---|---|
| Frontline Ventures | Transatlantic B2B technology investor | European pre-seed/seed; separate US growth strategy | B2B technology | Dublin office; European startups expanding toward the US |
| Delta Partners | Partner-led early venture firm | First investment through company scaling | Technology companies; confirm the current sector fit | Explicit Irish founder focus |
| Elkstone | Venture investor within a broader investment platform | Early-stage; confirm the current vehicle | Innovative companies; vehicle-specific | Dublin team and Irish venture focus; international portfolio also shown |
| FurthrVC | Early-stage venture investor | Initial seed through Series A; selected follow-ons later | Irish software and medtech | Born-global Irish companies |
| Atlantic Bridge | Cross-border technology investment platform | Growth equity; separate early research-commercialization vehicles | Deep technology | Dublin office; Europe, UK and US operating network |
| ACT Venture Capital | Technology venture firm | Early investment; confirm the current entry round | Technology; current examples span software, AI and engineering | Irish venture ecosystem and official pitch route |
| Kernel Capital | Venture and growth investment manager | Seed/early and growth portfolio routes; confirm new entry | Technology and science-led businesses | Distinct Irish and Northern Irish fund histories |
| SOSV | Global deep-tech venture and company-building platform | Pre-seed; program-specific | Human and planetary health; deep technology | Irish venture-association member; founder operating programs principally in the US |
| HBAN | All-island angel-investor network | Pre-seed and seed described | Multisector; company and syndicate-specific | Network operating across the island of Ireland |
| Enterprise Ireland Innovative HPSU Fund | Public startup equity co-investment route | High-potential startup; confirm the current funding route | Innovative internationally focused products and services | Ireland-linked company criteria assessed by Enterprise Ireland |
| Seroba | European life-science venture firm | Biotech and medtech; confirm the development-stage fit | Biotechnology and medical technology | Dublin office; European life-science strategy |
| Fountain Healthcare Partners | Life-science venture firm | Seed and early stage | Specialty pharma; biopharmaceuticals; medical devices; diagnostics | Dublin and New York offices; Europe and US remit |
| Western Development Commission | Regional public investment platform | Startup through scale-up; fund-specific | Multisector, including ICT, manufacturing, climate and medtech | Western Region of Ireland; confirm the company's regional connection |
| BVP | Irish company-finance and investment platform | Seed through growth; equity and debt routes differ | Climate; health; mobility; emerging technology | Irish investment ecosystem; company-specific financing |
| Hatch Blue | Specialist aquaculture investment platform | Investment and venture-development routes differ | Aquaculture; seafood; nutrition; genetics; enabling technology | Cork office within a global blue-economy platform |
| MiddleGame Ventures | Specialist financial-technology venture firm | Early-stage | Fintech and adjacent AI, cyber, deep tech and quantum applications | Pan-European mandate; confirm the applicable operating entity |
| Sure Valley Ventures | Early-stage AI venture manager | Initial pre-seed and seed; follow-ons to Series A | AI agents; application platforms; infrastructure; security and trust | UK and Ireland portfolios; separate funds and teams |
| Venturewave Capital | Impact-focused venture firm | Series A+ and Series B | Health; education; food/agriculture; climate; sustainable finance | Irish-registered manager; international growth and Impact Ireland vehicles |
For software, decide which side of the Atlantic comes next
Frontline makes the direction of travel explicit. Its Seed strategy backs early European B2B technology companies targeting the US, while Growth supports US companies entering Europe. An Irish startup's US ambition does not make it a Growth-strategy company.
Build a market-entry note with the buyer, current customer evidence, expected sales motion and what must be learned before hiring abroad. FurthrVC's born-global Irish software focus and ACT's early technology approach are different conversations again. Record the actual fund and decision rather than sending the same expansion paragraph everywhere.
For science-led companies, make the development risk visible
Seroba and Fountain specialize in life sciences. Atlantic Bridge also has deep-technology and research-commercialization connections, but the relevant vehicle matters. Hatch Blue focuses on aquaculture and seafood operating systems rather than generic climate positioning.
A useful science-company evidence pack identifies what has been demonstrated, under what conditions, the independent evidence and the next unresolved risk. Connect that work to a product and commercial route. A strong laboratory result and a repeatable sales process are both valuable, but neither should be reported as the other.
Check the regional connection before assuming national eligibility
The Western Development Commission has a regional investment purpose and offers both equity and loans. HBAN describes an all-island angel network. Kernel's fund history includes Irish and Northern Irish routes. Those geographic descriptions should remain visible in the shortlist.
Write headquarters, working team, customer markets and planned relocation separately. Confirm the particular program or fund with its responsible team. This guide does not decide eligibility, residency, incorporation or cross-border legal questions; obtain professional advice where those questions matter.
Do not count a manager, its fund and its investor product three times
BVP separates company financing from its investment products and investor network. Elkstone's venture founder route differs from its real estate and wealth propositions. Enterprise Ireland can support companies directly and also contribute capital to venture funds.
The person receiving the money determines the financing conversation. Count each manager once here, then identify the specific vehicle on the working record. A public-capital backer of a fund is not automatically another direct company investor, and a tax-relief investment product is not a startup grant.
Treat AI and impact as evidence questions, not pitch labels
Sure Valley Ventures' September 2026 update emphasizes AI-native products and real enterprise adoption. MiddleGame focuses on the financial-services job, including relevant adjacent technologies. Venturewave describes later early-growth companies with rapid revenue growth and measurable impact.
Explain the mechanism. What workflow changes because of the product? Who buys it, what evidence supports adoption, and what outcome can be measured? A label such as AI, fintech or impact should help select the right diligence questions, not substitute for an answer.
Investor profiles and official routes
These profiles are a research aid, not a performance ranking. Read the current strategy and portfolio before sharing a deck. A public contact route does not establish that a firm has available allocation for your round.
Frontline Ventures
Transatlantic B2B technology investor. Dublin office; European startups expanding toward the US. Frontline Seed addresses early European companies for which the US can become a major market. Frontline Growth goes in the other direction: established US companies expanding into Europe. An Irish founder should not combine the two mandates into one generic growth fund. State the buyer, product evidence and transatlantic operating plan.
Frontline Ventures: official investment information · Contact Us
Delta Partners
Partner-led early venture firm. Explicit Irish founder focus. Delta's current site describes backing Irish founders from the first cheque onward and working directly with a partner. Prepare the company foundations and milestone plan, not just an expansion narrative. Its history and current portfolio do not establish a universal cheque size or promise of allocation.
Delta Partners: official investment information
Elkstone
Venture investor within a broader investment platform. Dublin team and Irish venture focus; international portfolio also shown. Use Elkstone's founder-facing venture route. The platform also markets real estate, cash management and investor products, which are different conversations. Explain the product, existing evidence and next financing milestone; do not send a startup pitch through an investor subscription process.
Elkstone: official investment information · Contact us
FurthrVC
Early-stage venture investor. Born-global Irish companies. FurthrVC explicitly identifies Irish software and medtech companies and distinguishes initial investment from follow-on reserves. Explain the international business case alongside the evidence already achieved. Furthr's wider programs and angel activity should not be counted as multiple identical fund commitments.
FurthrVC: official investment information · Contact
Atlantic Bridge
Cross-border technology investment platform. Dublin office; Europe, UK and US operating network. The main platform describes a growth-equity and cross-border value-add strategy. University Bridge is a distinct vehicle within the wider ecosystem, not a reason to call every Atlantic Bridge conversation pre-seed. Identify the current fund and team, then explain the technical advantage and the international scaling task.
Atlantic Bridge: official investment information · Contact
ACT Venture Capital
Technology venture firm. Irish venture ecosystem and official pitch route. ACT describes leading early and staying with founders. Its current companies cover different technical and commercial jobs, so a portfolio match is a starting point rather than an eligibility rule. Use the official pitch route and make the product, customer evidence and next financing decision specific.
ACT Venture Capital: official investment information · Official founder pitch form
Kernel Capital
Venture and growth investment manager. Distinct Irish and Northern Irish fund histories. Kernel's current site distinguishes seed/early and growth companies and publishes ongoing portfolio activity. Identify the fund that can evaluate the company today rather than treating every historic vehicle as open. Northern Irish capital conditions are separate from Republic of Ireland operations and should be checked explicitly.
Kernel Capital: official investment information · CONTACT
SOSV
Global deep-tech venture and company-building platform. Irish venture-association member; founder operating programs principally in the US. SOSV can be relevant to an Irish team without being a local Irish accelerator. Its current operating locations include New York, Newark and San Francisco. Review the actual program, laboratory needs and participation requirements. Do not count HAX, a location or a founder event as another independent investor.
SOSV: official investment information · Additional official strategy or location evidence
HBAN
All-island angel-investor network. Network operating across the island of Ireland. HBAN connects startups and angel investors through its pitch process. Count the network once rather than turning every member or hub into committed capital. Its all-island reach does not eliminate differences between Republic of Ireland and Northern Ireland companies; the actual investment group evaluates each company.
HBAN: official investment information · Apply to pitch
Enterprise Ireland Innovative HPSU Fund
Public startup equity co-investment route. Ireland-linked company criteria assessed by Enterprise Ireland. The current HPSU information describes equity co-investment and an international-growth purpose. It is not interchangeable with a feasibility grant or a founder-readiness course. Confirm the current criteria, private-investor requirements and process with the responsible advisor; this guide does not determine eligibility or promise funding.
Enterprise Ireland Innovative HPSU Fund: official investment information · Current HPSU information and advisor route · Additional official strategy or location evidence
Seroba
European life-science venture firm. Dublin office; European life-science strategy. Seroba's current proposition centers on building businesses around scientific innovation. Prepare the result demonstrated, remaining development risk and commercial route. A general wellness app is not automatically equivalent to a biotech or medical-device opportunity; match the scientific and product evidence to the specialist team's focus.
Seroba: official investment information · Contact · Additional official strategy or location evidence
Fountain Healthcare Partners
Life-science venture firm. Dublin and New York offices; Europe and US remit. Fountain states its life-science sectors and early-stage focus directly. Show what the technology or therapeutic program does, the evidence already generated and the next development milestone. Do not confuse this Dublin-based manager with similarly named healthcare services funds or infer a promised exit timeline from marketing criteria.
Fountain Healthcare Partners: official investment information
Western Development Commission
Regional public investment platform. Western Region of Ireland; confirm the company's regional connection. The Western Investment Fund provides equity and loan routes and has a regional development purpose. Equity, debt and community finance are different instruments. Begin with the operating location and business investment route, then confirm the current terms directly; do not present a nationwide entitlement or grant award.
Western Development Commission: official investment information · Contact us
BVP
Irish company-finance and investment platform. Irish investment ecosystem; company-specific financing. BVP's current site separates company funding from tax-relief investment products and its private investor network. A founder needs the company-finance team and a clear financing purpose. Count the platform once, distinguish debt from equity, and ask an attorney or accountant about any tax or structuring questions rather than relying on headline relief claims.
BVP: official investment information · Additional official strategy or location evidence
Hatch Blue
Specialist aquaculture investment platform. Cork office within a global blue-economy platform. Hatch Blue separates Investments, Programs and Consulting. A venture-development studio can help build a company without being an equity commitment, and consulting is another service. Show the aquaculture or seafood operating problem, technical result and commercial application before selecting the relevant investment vehicle.
Hatch Blue: official investment information · Contact Us · Additional official strategy or location evidence
MiddleGame Ventures
Specialist financial-technology venture firm. Pan-European mandate; confirm the applicable operating entity. Its thesis is financial services, not every company using AI or cybersecurity. Explain the regulated or commercial workflow, buyer and value created within the financial system. An Irish founder should confirm the current team and vehicle; a European mandate does not mean every adjacent technology proposition fits.
MiddleGame Ventures: official investment information · Contact · Additional official strategy or location evidence
Sure Valley Ventures
Early-stage AI venture manager. UK and Ireland portfolios; separate funds and teams. The current svv.ai site states pre-seed and seed entry and an AI operating-workflow thesis. Prepare the technical differentiation and real external-customer evidence. Its older domain directs readers to svv.ai; the listed Sure Ventures investor vehicle is not a duplicate founder-facing manager. The September 2026 update supplies additional context, not a promise of funding.
Sure Valley Ventures: official investment information
Venturewave Capital
Impact-focused venture firm. Irish-registered manager; international growth and Impact Ireland vehicles. Venturewave's current approach asks for scaling businesses with rapid revenue growth and measurable impact. A company should show both the business result and how impact will be measured. Do not label an idea-stage social mission a Series A-ready company or confuse an advisory-council member with a separate direct investor.
Venturewave Capital: official investment information · Contact · Additional official strategy or location evidence
A worked shortlist for an Irish enterprise-AI startup
Illustrative exercise, not a financing recommendation. A Dublin software team has a functioning product, three paying enterprise customers and an initial US customer conversation. It seeks seed capital to validate repeatable demand. It has no therapeutic asset, aquaculture application or Series B growth record.
Turn the national directory into a focused research plan
| Route | Initial decision | Evidence or open question |
|---|---|---|
| Frontline Seed | Research the European-to-US B2B route | Show why the US can become a major customer market and what remains untested. |
| FurthrVC | Research the Irish software and seed fit | Connect customer evidence to the next internationally scalable milestone. |
| Sure Valley Ventures | Review the AI-native proposition | Explain why the product depends on the technology rather than merely adding an AI component. |
| Fountain | Hold without a life-science asset | Enterprise workflow software is not automatically a medical-device or biotech program. |
| Venturewave | Hold the current later-stage route | The example has not established the stated Series A+/B scaling case. |
The result is three specific research tasks and two justified holds, not an indiscriminate outreach list. Enterprise Ireland's current co-investment route can be discussed separately with an advisor rather than assumed as a round lead.
Copy your Irish investor shortlist worksheet
Use one record for each investor and specific vehicle. Keep the source date beside your fit decision.
IRELAND INVESTOR FIT CARD
Company + round: [product; buyer; stage; next proof point]
Operating facts: [Republic of Ireland / Northern Ireland / other; team; customers]
Manager + current vehicle: [name; team; strategy]
Capital type: [equity / angel / public co-investment / debt / building]
Mandate evidence: [stage; sector; geography + official URL/date]
Proof achieved: [technical result; MVP; revenue; independent evidence]
Expansion direction: [Ireland / Europe / US / other; facts versus plans]
Founder route: [official process; not LP subscriptions]
Open question + decision: [research / ask / hold]
Owner + next action: [person; action; date]Research the shortlist with Aurora, Claude or Codex
Give your AI teammate company facts you are authorized to share. Ask for sourced comparisons and open questions, not automatic introductions or outreach.
Be my Ireland-focused investor-research teammate.
Company: [product, buyer, stage and facts I may share]
Next financing milestone: [what this round must prove]
Operating map: [headquarters, team, customer markets, expansion plans]
Candidates: [five managers or networks from this guide]
Check current primary sources; identify the actual team and vehicle.
Separate Irish, Northern Irish, pan-European and US program conditions.
Distinguish company equity, public co-investment, loans and LP products.
Match software, science, fintech or impact evidence to the real mandate.
Return source/date, fit evidence, missing proof and the next research action.
Deduplicate managers, fund vehicles and historic names.
Do not invent cheque sizes, eligibility, open allocation or introductions.
Do not contact anyone, apply, subscribe or submit materials.Keep the resulting investor records, relationship context and next actions together in Finta. The investor-prospecting workflow covers the next execution step.
Methodology, research date and local guides
Research checked October 29, 2026 by the Finta Editorial Team with AI-assisted source review. We reconciled provider names from our existing city research and reviewed current official strategy, portfolio, location or founder-contact pages. Firms with multiple offices count once; angel networks count as networks, not one committed pooled fund. We distinguish local presence from investment mandate and company eligibility. We do not infer check sizes, investor returns, lead behavior or open allocation from a portfolio logo.
Discovery combined the established Dublin research with current Irish Venture Capital & Private Equity Association members and official manager pages. That association includes multiple investment types, so membership alone was not used as proof of a startup mandate. Added research covers western-region capital, Cork aquaculture expertise, life sciences, fintech and impact investing. SOSV's current founder locations are labeled international rather than presented as Irish facilities.
Informational purposes only. Finta is not a law firm or accounting firm. This is general fundraising information, not personalized financial, legal or tax advice. Ask your attorney or accountant about financing documents, tax-relief structures, company residence and cross-border requirements; confirm program eligibility with the responsible provider.
This is a selected research directory, not an exhaustive register or sponsored ranking. Confirm the current vehicle, team and process directly before relying on a fit decision.
Make the next fundraising step specific
Choose a small set of defensible matches, record the open question, and assign the next action. Use our investor-shortlist guide and warm-introduction guide to prepare the conversation. A longer list should make the research better, not turn into an indiscriminate mailing list.